CN107753858A - A kind of capsule medicine and preparation method for being used to treat mid-term lung cancer - Google Patents
A kind of capsule medicine and preparation method for being used to treat mid-term lung cancer Download PDFInfo
- Publication number
- CN107753858A CN107753858A CN201711107390.2A CN201711107390A CN107753858A CN 107753858 A CN107753858 A CN 107753858A CN 201711107390 A CN201711107390 A CN 201711107390A CN 107753858 A CN107753858 A CN 107753858A
- Authority
- CN
- China
- Prior art keywords
- medicine
- lung cancer
- mid
- treat
- chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 48
- 206010058467 Lung neoplasm malignant Diseases 0.000 title claims abstract description 35
- 201000005202 lung cancer Diseases 0.000 title claims abstract description 35
- 208000020816 lung neoplasm Diseases 0.000 title claims abstract description 35
- 239000002775 capsule Substances 0.000 title claims abstract description 21
- 238000002360 preparation method Methods 0.000 title description 10
- 240000009138 Curcuma zedoaria Species 0.000 claims abstract description 12
- 241000218916 Cycas Species 0.000 claims abstract description 11
- 241000123069 Ocyurus chrysurus Species 0.000 claims abstract description 11
- 241000283966 Pholidota <mammal> Species 0.000 claims abstract description 11
- 244000138993 panchioli Species 0.000 claims abstract description 11
- 239000002023 wood Substances 0.000 claims abstract description 11
- 241000234653 Cyperus Species 0.000 claims abstract description 10
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 10
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 10
- 241000218989 Trichosanthes Species 0.000 claims abstract description 6
- 239000000463 material Substances 0.000 claims description 12
- 229920002472 Starch Polymers 0.000 claims description 8
- 235000019698 starch Nutrition 0.000 claims description 8
- 239000008107 starch Substances 0.000 claims description 8
- 235000003405 Curcuma zedoaria Nutrition 0.000 abstract description 9
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 abstract description 9
- 235000019509 white turmeric Nutrition 0.000 abstract description 9
- 235000014375 Curcuma Nutrition 0.000 abstract description 8
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 abstract description 8
- 229940079593 drug Drugs 0.000 abstract description 5
- 244000164480 Curcuma aromatica Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 12
- 208000002193 Pain Diseases 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 239000000796 flavoring agent Substances 0.000 description 9
- 235000019634 flavors Nutrition 0.000 description 9
- 230000036407 pain Effects 0.000 description 9
- 244000163122 Curcuma domestica Species 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 206010001928 Amenorrhoea Diseases 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 206010000077 Abdominal mass Diseases 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 208000032843 Hemorrhage Diseases 0.000 description 4
- 230000035508 accumulation Effects 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- 230000000740 bleeding effect Effects 0.000 description 4
- 210000000038 chest Anatomy 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 208000034507 Haematemesis Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 238000002386 leaching Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000000391 smoking effect Effects 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 208000034158 bleeding Diseases 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 210000000697 sensory organ Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 235000003097 Artemisia absinthium Nutrition 0.000 description 1
- 240000001851 Artemisia dracunculus Species 0.000 description 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- 240000007311 Commiphora myrrha Species 0.000 description 1
- 235000006965 Commiphora myrrha Nutrition 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 244000178320 Vaccaria pyramidata Species 0.000 description 1
- 235000010587 Vaccaria pyramidata Nutrition 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000037006 agalactosis Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 239000001138 artemisia absinthium Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 239000003500 flue dust Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000002601 intratumoral effect Effects 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000003950 pathogenic mechanism Effects 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 238000009936 smoking Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 239000010681 turmeric oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/902—Sparganiaceae (Bur-reed family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Dermatology (AREA)
- Insects & Arthropods (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention belongs to field of traditional Chinese, it is therefore an objective to a kind of capsule medicine for being used to treat mid-term lung cancer be provided according to the understanding mechanism of Chinese traditional treatment mid-term lung cancer, each component and its mass parts ratio of the medicine are as follows:30~90g of pangolin, 30~100g of dried orange peel, 50~100g of Rhizoma Sparganii, 90~160g of dalbergia wood, 30~120g of curcuma zedoary, public 150~550g of English, 15~70g of Pu Qingdai, 30~100g of radix scutellariae, 150~250g of root of Chinese trichosanthes, 100~650g of PORIA ALBA, 30~120g of ground bettle, 50~120g of the rhizome of nutgrass flatsedge, 60~100g of madder, 150~350g of folium cycas;Medicine provided by the invention is a good Chinese prescription.
Description
Technical field
The invention belongs to field of traditional Chinese, and in particular to a kind of capsule medicine for being used to treat mid-term lung cancer, especially
It is the field of the capsule medicine and preparation method used for mid-term patients with lung cancer.
Background technology
Doctor thinks:Lung cancer is that morbidity and mortality growth is most fast, and maximum to population health and life threat is pernicious
One of tumour.Many countries all report that the morbidity and mortality of lung cancer substantially increase in the past 50 years, the male lung cancer incidence of disease
First of all malignant tumours is accounted for the death rate, the women incidence of disease accounts for second, and the death rate accounts for second.The cause of disease of lung cancer
So far not completely clearly, great mass of data shows, long-term a large amount of smokings and lung cancer have very close relationship.It is existing
Research has shown that:The probability that long-term a large amount of smokers suffer from lung cancer is 10~20 times of non-smoker, and it is smaller to start the age of smoking, suffers from
The probability of lung cancer is higher.In addition, smoking not only directly affects my health, the also health generation to surrounding population is bad
Influence, cause involuntary smoker's lung cancer illness rate substantially to increase.The incidence of disease of city dweller's lung cancer is higher than rural area, and this may be with city
City's atmosphere pollution with flue dust contain carcinogen it is relevant.
So, just how to find a kind of Chinese medicine composition that can effectively treat mid-term lung cancer, be those skilled in the art urgently
The problem of to be resolved.
The content of the invention
With the continuous development of China's traditional Chinese medicine, in the treatment in phase lung cancer, people gradually appreciate middle treatment
The advantages for the treatment of mid-term lung cancer, and good effect, the advantage such as quick, toxic side effect is small over the course for the treatment of, control for existing doctor trained in Western medicine
The present situation of mid-term lung cancer is treated, the purpose of the present invention is to be to provide a kind of capsule medicine for being used to treat mid-term lung cancer, with solution
The problem of certainly mid-term patients with lung cancer is got well and extends life cycle early.The medicine is using common Chinese medicine as raw material, is passed through
Rational medicine and mass parts ratio are selected, above-mentioned mid-term lung cancer one can be effectively treated and demonstrate,prove.
To reach the purpose of foregoing invention, the technical solution adopted in the present invention is:There is provided a kind of for treating mid-term lung
The capsule medicine and preparation method of cancer, it is characterised in that each component and mass parts of the medicine are than as follows:
30~90g of pangolin, 30~100g of dried orange peel, 50~100g of Rhizoma Sparganii, 90~160g of dalbergia wood, 30~120g of curcuma zedoary, public English 150
15~70g of~550g, Pu Qingdai, 30~100g of radix scutellariae, 150~250g of root of Chinese trichosanthes, 100~650g of PORIA ALBA, ground bettle 30~
120g, 50~120g of the rhizome of nutgrass flatsedge, 60~100g of madder, 150~350g of folium cycas, auxiliary material:Appropriate starch.
It is a kind of to be used to treat the capsule medicine and preparation method of mid-term lung cancer, it is characterised in that the medicine it is each
Component and mass parts are than as follows:
38~80g of pangolin, 38~90g of dried orange peel, 58~90g of Rhizoma Sparganii, 100~140g of dalbergia wood, 38~105g of curcuma zedoary, public English 180
20~60g of~480g, Pu Qingdai, 38~90g of radix scutellariae, 180~220g of root of Chinese trichosanthes, 115~560g of PORIA ALBA, ground bettle 38~
105g, 58~105g of the rhizome of nutgrass flatsedge, 70~90g of madder, 180~310g of folium cycas, auxiliary material:Appropriate starch.
It is a kind of to be used to treat the capsule medicine and preparation method of mid-term lung cancer, it is characterised in that the medicine it is each
Component and mass parts are than as follows:
Pangolin 70g, dried orange peel 80g, Rhizoma Sparganii 80g, dalbergia wood 120g, curcuma zedoary 95g, public English 420g, Pu Qingdai 52g, radix scutellariae 80g, day
Pollen 200g, PORIA ALBA 500g, ground bettle 95g, rhizome of nutgrass flatsedge 95g, madder 80g, folium cycas 280g, auxiliary material:Appropriate starch.
A kind of capsule medicine and preparation method for being used to treat mid-term lung cancer, it is characterised in that methods described is included such as
Lower step is prepared:
A, except Pu Qingdai(Separately grind as superfine end)Outside, after above-mentioned other raw material Chinese medicines being picked into impurity and dust, according to mass parts
Decocted a drug wrapped than being respectively crushed into coarse;
B, the raw material Chinese medicine wrapped is put into after soaking 40min in cold boiling water, then soaked medicine is put into marmite and decocted
Three times:1. amount of water is 9~10 times of medicinal material total amount, high heat decoction is first carried out, when 15min is arrived in decoction, turns slow fire and boils 115
Min, leaching decoction;2. amount of water is 8~9 times of dry dregs of a decoction total amount, high heat decoction is first carried out, when 10min is arrived in decoction, is turned
Slow fire boils 105 min, leaching decoction;3. amount of water is 7~8 times of dry dregs of a decoction total amount, high heat decoction is first carried out, waits to decoct
During to 8min, turn slow fire and boil 90 min, leaching decoction;4. merging decoction three times, and it is concentrated under reduced pressure into every milliliter contained 3g
Standard after, that is, obtain drug extract.
C, by the extract dry prepared in above-mentioned B, sterilization, and it is standby according to mass parts ratio to be ground into superfine end;
D, the method for preparing Chinese medicine capsules according to traditional common process and auxiliary material, by superfine myrrh ground in A and C
After thing sieving, and auxiliary material is put into medicine device and is well mixed in the lump, is then prepared into capsule(Total length after its capsule is sealed is
23.3mm, medicinal powder capacity 0.4~0.5g/ grains), then polish, sterilize, sealed packaging produces.
It is a kind of to be used to treat the capsule medicine and preparation method of mid-term lung cancer, it is characterised in that the instructions of taking is:
By the capsule medicine prepared three times a day to take, once a dose in the morning, afternoon and evening, dosage 2g(4)/ time, half an hour after meal
Warm water delivery service.60 days are a course for the treatment of, and 2 courses for the treatment of of taking medicine, symptom gradually mitigates, and extends the life cycle of patient.
Each raw material Chinese medicine in prescription of the present invention has detailed note in Chinese Pharmacopoeia, Chinese dictionary and China's book on Chinese herbal medicine
Carry.The present invention is raw material from most common of which Chinese medicine, gives full play to the pharmacological effect of each component:
Pangolin, nature and flavor:It is salty, cool, big poison, there is blood circulation promoting and dispersing pathogen accumulation, stimulate the menstrual flow lower breast, anti-stain in solid the effect of, for treating blood stasis
Amenorrhea, abdominal mass, arthralgia pain due to rheumatism, agalactia, carbuncle swells, scrofula, for Jing Bi wei lump in the abdomen, alactation, carbuncle sore tumefacting virus, joint numbness
Bitterly, the disease such as numbness contracture;
Dried orange peel, nature and flavor:Warm-natured, acrid flavour, bitter, have in regulating qi-flowing for strengthening spleen, tune, eliminating dampness, clears phlegm, for treating taste gas
Stagnant abdominal fullness and distention or pain, indigestion, the abdominal distension uncomfortable in chest in wet turbid resistance, indigestion and loss of appetite loose stool, the cough and asthma of phlegm obstructing lung, also
For chest gastral cavity turgor, deficiency of food vomiting and diarrhoea, coughing with a lot of sputum;
Rhizoma Sparganii, nature and flavor:It is pungent, bitter, flat, there is the effect of blood-breaking, Xiao Ji Zhi Tong, for treating abdominal mass lump in the abdomen, dysmenorrhoea, hemostasis
Amenorrhea, chest impediment and cardialgia, dyspepsia distending pain;
Dalbergia wood, nature and flavor:It is pungent, warm, there is the effect of removing blood stasis and hemostasis, regulating qi-flowing for relieving pain, for treating haematemesis, bleeding from five sense organs or subcutaneous tissue, traumatism and bleeding, liver
The diseases such as strongly fragrant hypochondriac pain, obstruction of qi in the chest shouting pain, the pain of injury caused by falling and tumbling, vomiting stomachache;
Curcuma zedoary, nature and flavor:Toil, temperature, there is the effect of blood-breaking, Xiao Ji Zhi Tong, for treat pained vim and vigour, eating accumulation,
Abdominal distention, amenorrhea due to stagnation of blood, dysmenorrhoea, abdominal mass knurl lump in the abdomen, traumatic injury, be additionally operable to abdominal pain due to blood stasis, hepatosplenomegaly, trusted subordinate's distending pain,
Accumulation, abdominal mass lump, women's blood stasis, traumatic injury are had a pain eating accumulation, and it is antitumor that modern pharmacology shows that oriental wormwood has
Effect:Its aromatic turmeric oil preparation is in vitro to Mouse Ehrlich Carcinoma Cells, the L615 leukaemia of 615 mouse inbred lines and ascitic type
The growth of a variety of knurl strains such as liver cancer cells has obvious suppression and destruction.Clinic makees intratumoral injection uterine neck with oil of zedoary turmeric
Cancer, after treatment visible tumor tissue necrosis come off, local lymphocytes infiltration, some cases lump disappear, uterine neck is smooth, prompt cowherb
Art plays the role of directly to kill oncocyte;
Public English, nature and flavor:Sweet, slight bitter, tremble with fear, there is the effect of clearing heat and detoxicating, carbuncle that disappears dissipating bind, for treatmentization heat toxin, the swollen knot of the evil that disappears
Core, Detoxicating food-poisoning, dissipate the diseases such as stagnant gas;
Pu Qingdai, nature and flavor:Taste is salty, cold in nature, has the effect of clearing heat and detoxicating, cooling blood and hemostasis, clearing liver-fire, for treating warm disease heat
Malicious macula, blood-head haematemesis, bleeding from five sense organs or subcutaneous tissue, spitting of blood, the hot frightened epilepsy of liver, liver-fire attacking lung cough, abscess of throat, erysipelas, Zha, sore swells, snakeworm sting
Wound;
Radix scutellariae, nature and flavor:It is bitter, cold in nature, have clearing heat-fire, eliminating dampness removing toxic substances, hemostasis, it is antiabortive the effect of, for treating lung heat cough
Cough, the headache of high fever apoplexy coma due to blocking of the respiratory system shies epilepsy, irascibility, red eye, swell pain, jaundice with damp-heat pathogen, rush down dysentery, heat gonorrhea, hematemesis blood, uterine bleeding, fetal movement with fever, carbuncle
Swollen furunculosis;
Root of Chinese trichosanthes, nature and flavor:Sweet, slight bitter, cold nature, there is the effect of clearing heat and promoting fluid, moistening lung for removing phlegm, dense detumescence row, for controlling
Treatment pyreticosis is thirsty, the diseases such as more drink, lung-heat type cough, sore swollen toxins of quenching one's thirst;
PORIA ALBA, nature and flavor:It is sweet light, flat, there is the effect of removing damp-heat, let out turbid removing toxic substances, be easing joint movement, for treating syphilis, leaching
Turbid, diarrhea, muscles and bones contraction pain, tinea pedis, carbuncle swells, sore tinea, scrofula, goiter and tumor and mercury poisoning etc.;
Ground bettle, nature and flavor:Taste is salty, cold in nature, has the effect of dissipating blood stasis with potent drugs, reunion of fractured tendons and bones, for treating traumatic injury, injury of tendon and muscle bone
The illnesss such as folding, blood stasis, postpartum stasis stomachache, addiction lump in the abdomen lump in the abdomen;
The rhizome of nutgrass flatsedge, nature and flavor:Acrid flavour, be slightly cold, it is nontoxic, have regulating the flow of vital energy Xie Yu, menstruction regulating and pain relieving, it is antiabortive the effect of, for treating side of body rib
Under distending pain, breast swelling, hernia pain, irregular menstruation, epigastric abdominal fullness pain, belch acid regurgitation, evil of vomitting, dysmenorrhea, uterine bleeding band,
The diseases such as fetal irritability;
Madder, nature and flavor:Cold in nature, bitter, there is cool blood, hemostasis, dissolving stasis, the effect of stimulating the menstrual flow, for treat haematemesis, bleeding from five sense organs or subcutaneous tissue, uterine bleeding,
The diseases such as traumatism and bleeding, the resistance of Amenorrhea block up, joint pain, tumbling and swelling;
Folium cycas, nature and flavor:Sweet, sour, slightly warm in nature, have the effect of blood stasis dispersing and deswelling and stomach dissipating bind, for treat stomachache, amenorrhoea,
The diseases such as cough, haematemesis, cancerous swelling, traumatic injury.
Medicine of the present invention is the principle based on Chinese traditional treatment mid-term lung cancer, from the pathomechanism and pharmacology according to mid-term lung cancer
Effect is thought:With regard to mid-term lung cancer, each raw material herbal medicine efficacy in medicine provided by the present invention is played altogether, is had very well to above-mentioned disease
Therapeutic effect.
Embodiment
A kind of Chinese medicine preparation that the present invention proposes aiming at the treatment of above-mentioned mid-term lung cancer, prepared using the formula
Medicine effect is good, quick, is a good Chinese prescription, is particularly suitable for Clinical practice.With reference to the specific of the present invention
Embodiment is described in further detail:
Embodiment 1:
A kind of capsule medicine for being used to treat mid-term lung cancer, it is characterised in that each component and mass parts ratio of the medicine
It is as follows:
Pangolin 70g, dried orange peel 80g, Rhizoma Sparganii 80g, dalbergia wood 120g, curcuma zedoary 95g, public English 420g, Pu Qingdai 52g, radix scutellariae 80g, day
Pollen 200g, PORIA ALBA 500g, ground bettle 95g, rhizome of nutgrass flatsedge 95g, madder 80g, folium cycas 280g, auxiliary material:Appropriate starch.
Embodiment 2:
A kind of capsule medicine for being used to treat mid-term lung cancer, it is characterised in that each component and mass parts ratio of the medicine
It is as follows:
Pangolin 70g, dried orange peel 80g, Rhizoma Sparganii 80g, dalbergia wood 120g, curcuma zedoary 95g, public English 420g, Pu Qingdai 52g, radix scutellariae 80g, day
Pollen 200g, PORIA ALBA 500g, ground bettle 95g, rhizome of nutgrass flatsedge 95g, madder 80g, folium cycas 280g, auxiliary material:Appropriate starch.
Embodiment 3:
A kind of capsule medicine for being used to treat mid-term lung cancer, it is characterised in that each component and mass parts ratio of the medicine
It is as follows:
Pangolin 90g, dried orange peel 100g, Rhizoma Sparganii 100g, dalbergia wood 160g, curcuma zedoary 120g, public English 550g, Pu Qingdai 70g, radix scutellariae
100g, root of Chinese trichosanthes 250g, PORIA ALBA 650g, ground bettle 120g, rhizome of nutgrass flatsedge 120g, madder 100g, folium cycas 350g, auxiliary material:Form sediment
Appropriate powder.
Model case:
Through clinical conditions mid-term patients with lung cancer totally 1285, the age is 742 of more than 67 years old, and only 543 are 67 years old
Below.Extend life cycle in 1285 patients has 370, effective 414, invalid 501.Total effective rate is up to 61%.
Claims (3)
1. a kind of capsule medicine for being used to treat mid-term lung cancer, it is characterised in that each component and its quality of the medicine
Part is than as follows:
30~90g of pangolin, 30~100g of dried orange peel, 50~100g of Rhizoma Sparganii, 90~160g of dalbergia wood, 30~120g of curcuma zedoary, public English 150
15~70g of~550g, Pu Qingdai, 30~100g of radix scutellariae, 150~250g of root of Chinese trichosanthes, 100~650g of PORIA ALBA, ground bettle 30~
120g, 50~120g of the rhizome of nutgrass flatsedge, 60~100g of madder, 150~350g of folium cycas, auxiliary material:Appropriate starch.
2. according to claim 1 be used to treat the capsule medicine of mid-term lung cancer, it is characterised in that the medicine it is each
Individual component and its mass parts are than as follows:
38~80g of pangolin, 38~90g of dried orange peel, 58~90g of Rhizoma Sparganii, 100~140g of dalbergia wood, 38~105g of curcuma zedoary, public English 180
20~60g of~480g, Pu Qingdai, 38~90g of radix scutellariae, 180~220g of root of Chinese trichosanthes, 115~560g of PORIA ALBA, ground bettle 38~
105g, 58~105g of the rhizome of nutgrass flatsedge, 70~90g of madder, 180~310g of folium cycas, auxiliary material:Appropriate starch.
3. the capsule medicine for being used to treat mid-term lung cancer according to claim 1 to 2, it is characterised in that the medicine
Each component and its mass parts than as follows:
Pangolin 70g, dried orange peel 80g, Rhizoma Sparganii 80g, dalbergia wood 120g, curcuma zedoary 95g, public English 420g, Pu Qingdai 52g, radix scutellariae 80g, day
Pollen 200g, PORIA ALBA 500g, ground bettle 95g, rhizome of nutgrass flatsedge 95g, madder 80g, folium cycas 280g, auxiliary material:Appropriate starch.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711107390.2A CN107753858A (en) | 2017-11-10 | 2017-11-10 | A kind of capsule medicine and preparation method for being used to treat mid-term lung cancer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711107390.2A CN107753858A (en) | 2017-11-10 | 2017-11-10 | A kind of capsule medicine and preparation method for being used to treat mid-term lung cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107753858A true CN107753858A (en) | 2018-03-06 |
Family
ID=61272811
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711107390.2A Withdrawn CN107753858A (en) | 2017-11-10 | 2017-11-10 | A kind of capsule medicine and preparation method for being used to treat mid-term lung cancer |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107753858A (en) |
-
2017
- 2017-11-10 CN CN201711107390.2A patent/CN107753858A/en not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104998197A (en) | Traditional Chinese medicine composition for treating liver cancer | |
CN103908616B (en) | The medicament of tumor remission patient radiotherapy side effect and preparation method | |
CN107753858A (en) | A kind of capsule medicine and preparation method for being used to treat mid-term lung cancer | |
CN104491538A (en) | Traditional Chinese medicine composition for treating cerebral hemorrhage | |
CN107753853A (en) | A kind of endo-medicine for treating epigastric pain and preparation method thereof | |
CN105434670A (en) | Traditional Chinese medicine preparation for treating costal chondritis and preparation method thereof | |
CN104706866A (en) | Traditional Chinese medicine preparation for treating enteritis and preparation method of traditional Chinese medicine preparation | |
CN107898949A (en) | A kind of Chinese medicine preparation for treating lung cancer and preparation method thereof | |
CN107469003A (en) | A kind of endo-medicine and preparation method for treating the postoperative syndrome of qi stagnation and blood stasis of thyroid cancer | |
CN107802803A (en) | It is a kind of to be used to treat endo-medicine of lung cancer and preparation method thereof | |
CN107929614A (en) | A kind of traditional Chinese medicine for oral administration ball for treating breast cancer and preparation method | |
CN107823553A (en) | A kind of capsule medicine and preparation method for treating breast cancer | |
CN107469054A (en) | It is a kind of effectively to treat endo-medicine of peptic ulcer and preparation method thereof | |
CN106943503A (en) | A kind of Chinese medicine composition and preparation method for being used to treat trigeminal neuralgia | |
CN107753706A (en) | A kind of traditional Chinese medicine for oral administration ball for treating lung cancer and preparation method thereof | |
CN107929574A (en) | It is a kind of to be used to treat endo-medicine of lung cancer and preparation method thereof | |
CN107261099A (en) | It is a kind of to be used to treat pill medicine of gastritis and preparation method thereof | |
CN107596311A (en) | A kind of pill medicine and preparation method for treating qi depression to blood stasis and myomata tumour disease | |
CN107596213A (en) | A kind of Chinese medicine composition for treating fibroid and preparation method thereof | |
CN107802788A (en) | A kind of capsule medicine and preparation method for being used to treat gout | |
CN107753863A (en) | A kind of capsule medicine for treating early-stage cancer and preparation method thereof | |
CN107468854A (en) | A kind of Chinese medicine composition for treating osteoporosis and preparation method thereof | |
CN107823468A (en) | A kind of capsule medicine and preparation method for treating the early stage of lung cancer | |
CN107753869A (en) | A kind of pill medicine and preparation method for being used to treat the early stage of lung cancer | |
CN107929656A (en) | A kind of pill medicine and preparation method that can effectively treat lung cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20180306 |